Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol vs MgSO4 for Prevention of Eclampsia
NCT00293735Phase 3Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- Jun 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of labetalol in eclampsia, sponsored by Baylor College of Medicine. Planned start Jun 2015; status: withdrawn.
02
Drugs
labetalol
03
Conditions
eclampsia
Beyond the preview
Go deeper on NCT00293735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293735.